| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―17 |
Human Genetic and Immunological Determinants of SARS-CoV-2 Infection and Multisystem Inflammatory Syndrome in Children |
Halima Kholaiq, Yousra Abdelmoumen, Abderrahmane Moundir, Assiya El Kettani, Fatima Ailal, Ibtihal Benhsaien, Fatima Adnane, Asmaa Drissi Bourhanbour, Naima Amenzoui, Jalila El Bakkouri, Ahmed Aziz Bousfiha |
| 2 |
[GO] |
2024―Jul―02 |
Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19 |
Elena Woods, Adriana Mena, Sophie Sierpinska, Emily Carr, Richard Hagan, John Crowley, Colm Bergin, David Clark, Caroline Brophy, Derek Macallan, Clair M Gardiner |
| 3 |
[GO] |
2024―May―02 |
Follow-up of Immune Response in Patients with Common Variable Immunodeficiency following SARS-CoV-2 Vaccination |
Juan Francisco Gutiérrez-Bautista, Irene Díaz-Alberola, María Tarriño, María Aguilera, Fernando Cobo, Juan Antonio Reguera, Javier Rodríguez-Granger, Joaquín Mendoza, Miguel Ángel López-Nevot, Antonio Sampedro |
| 4 |
[GO] |
2024―Apr―20 |
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery |
Mohammad Ali, Stephanie Longet, Isabel Neale, Patpong Rongkard, Forhad Uddin Hassan Chowdhury, Jennifer Hill, Anthony Brown, Stephen Laidlaw, Tom Tipton, Ashraful Hoque, Nazia Hassan, Carl-Philipp Hackstein, Sandra Adele, Hossain Delowar Akther, Priyanka Abraham, Shrebash Paul, Md Matiur Rahman, Md Masum Alam, Shamima Parvin, Forhadul Hoque Mollah, Md Mozammel Hoque, Shona C Moore, Subrata K Biswas, Lance Turtle, Thushan I de Silva, Ane Ogbe, John Frater, Eleanor Barnes, Adriana Tomic, Miles W Carroll, Paul Klenerman, Barbara Kronsteiner, Fazle Rabbi Chowdhury, Susanna J Dunachie |
| 5 |
[GO] |
2023―Aug―11 |
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19 |
Rohan Ameratunga, Emily Mears, Euphemia Leung, Russell Snell, See-Tarn Woon, William Kelton, Natalie Medlicott, Anthony Jordan, William Abbott, Richard Steele, William Rolleston, Hilary Longhurst, Klaus Lehnert |
| 6 |
[GO] |
2023―Jun―20 |
Efficacy and safety of MAS825 (anti-IL-1ꞵ/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function |
Alex D Hakim, Mustafa Awili, Hollis R O’Neal, Omar Siddiqi, Naseem Jaffrani, Richard Lee, Jeffrey S Overcash, Ann Chauffe, Terese C Hammond, Bela Patel, Michael Waters, Gerard J Criner, Alok Pachori, Guido Junge, Rafael Levitch, Jen Watts, Philip Koo, Tirtha Sengupta, Lili Yu, Michael Kiffe, Anne Pinck, Richard R Stein, Jamie Bendrick-Peart, Janet Jenkins, Marianna Rowlands, Frank Waldron-Lynch, Jesse Matthews |
| 7 |
[GO] |
2023―Jun―14 |
Identification of differences in the magnitude and specificity of SARS-CoV-2 nucleocapsid antibody responses in naturally infected and vaccinated individuals |
Pradeep D Pushpakumara, Chandima Jeewandara, Farha Bary, Deshan Madushanka, Lahiru Perera, Inoka Sepali Aberathna, Thashmi Nimasha, Jeewantha Jayamali, Thushali Ranasinghe, Heshan Kuruppu, Saubhagya Danasekara, Ananda Wijewickrama, Graham S Ogg, Gathsaurie Neelika Malavige |
| 8 |
[GO] |
2023―Apr―25 |
SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection |
Kerensa E Ward, Lora Steadman, Abid R Karim, Gary M Reynolds, Matthew Pugh, Winnie Chua, Sian E Faustini, Tonny Veenith, Ryan S Thwaites, Peter J M Openshaw, Mark T Drayson, Adrian M Shields, Adam F Cunningham, David C Wraith, Alex G Richter |
| 9 |
[GO] |
2023―Apr―19 |
New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination |
Yang Yang, Yi Xiong, Gaosi Xu |
| 10 |
[GO] |
2023―Apr―18 |
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses |
Anna Lundgren, Susannah Leach, Hannes Axelsson, Pauline Isakson, Kristina Nyström, Lydia Scharf, Bengt A Andersson, Nicolae Miron, Emelie Marklund, Lars-Magnus Andersson, Magnus Gisslen, Davide Angeletti, Mats Bemark |
| 11 |
[GO] |
2023―Mar―04 |
Down-regulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19 |
Shoumit Dey, Helen Ashwin, Luke Milross, Bethany Hunter, Joaquim Majo, Andrew J Filby, Andrew J Fisher, Paul M Kaye, Dimitris Lagos |
| 12 |
[GO] |
2023―Feb―21 |
Evaluation of QuantiFERON SARS-CoV-2 interferon- release assay following SARS-CoV-2 infection and vaccination |
Síle A Johnson, Eloise Phillips, Sandra Adele, Stephanie Longet, Tom Malone, Chris Mason, Lizzie Stafford, Anni Jamsen, Siobhan Gardiner, Alexandra Deeks, Janice Neo, Emily J Blurton, Jemima White, Muhammed Ali, Barbara Kronsteiner, Joseph D Wilson, Dónal T Skelly, Katie Jeffery, Christopher P Conlon, Philip Goulder, Miles Carroll, Eleanor Barnes, Paul Klenerman, Susanna J Dunachie |
| 13 |
[GO] |
2023―Feb―02 |
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials |
Merryn Voysey, Amy Flaxman, Jeremy Aboagye, Parvinder K Aley, Sandra Belij-Rammerstorfer, Sagida Bibi, Mustapha Bittaye, Federica Cappuccini, Sue Charlton, Elizabeth A Clutterbuck, Sophie Davies, Christina Dold, Nick J Edwards, Katie J Ewer, Saul N Faust, Pedro M Folegatti, Jamie Fowler, Ciaran Gilbride, Sarah C Gilbert, Leila Godfrey, Bassam Hallis, Holly E Humphries, Daniel Jenkin, Simon Kerridge, Yama F Mujadidi, Emma Plested, Maheshi N Ramasamy, Hannah Robinson, Helen Sanders, Matthew D Snape, Rinn Song, Kelly M Thomas, Marta Ulaszewska, Danielle Woods, Daniel Wright, Andrew J Pollard, Teresa Lambe |
| 14 |
[GO] |
2022―Dec―08 |
The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination - Lessons learned from the SARS-CoV-2 pandemic |
Stefanía P Bjarnarson, Siggeir F Brynjólfsson |
| 15 |
[GO] |
2022―Aug―16 |
COVID-19 infection and vaccination in immunodeficiency |
Eva Piano Mortari, Federica Pulvirenti |
| 16 |
[GO] |
2022―Jun―26 |
Risk Stratification through Allergy History: Single-centre Experience of Specialised COVID-19 Vaccine Clinic |
Daniel Lyons, Cliodhna Murray, Siobhan Hannigan, Jacklyn Sui, Salma Alamin, Niall Conlon, Mary Keogan, Khairin Khalib, Chris Fitzpatrick, Jonathan O’B Hourihane, Michael Carey, J David M Edgar |
| 17 |
[GO] |
2022―May―06 |
Comparison of two T cell assays to evaluate T cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers |
Eloise Phillips, Sandra Adele, Tom Malone, Alexandra Deeks, Lizzie Stafford, Susan L Dobson, Ali Amini, Donal Skelly, David Eyre, Katie Jeffery, Christopher P Conlon, Christina Dold, Ashley Otter, Silvia D’ Arcangelo, Lance Turtle, Paul Klenerman, Eleanor Barnes, Susanna J Dunachie |
| 18 |
[GO] |
2022―Jan―31 |
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the United Kingdom |
Adrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, Kenneth Baker, Sameer Bahal, Helen Baxendale, William Bermingham, Malini Bhole, Evon Boules, Philip Bright, Charu Chopra, Lucy Cliffe, Betsy Cleave, John Dempster, Lisa Devlin, Fatima Dhalla, Lavanya Diwakar, Elizabeth Drewe, Christopher Duncan, Magdalena Dziadzio, Suzanne Elcombe, Shuayb Elkhalifa, Andrew Gennery, Harichandrana Ghanta, Sarah Goddard, Sofia Grigoriadou, Scott Hackett, Grant Hayman, Richard Herriot, Archana Herwadkar, Aarnoud Huissoon, Rashmi Jain, Stephen Jolles, Sarah Johnston, Sujoy Khan, James Laffan, Peter Lane, Lucy Leeman, David M Lowe, Shanti Mahabir, Dylan James Mac Lochlainn, Elizabeth McDermott, Siraj Misbah, Fiona Moghaddas, Hadeil Morsi, Sai Murng, Sadia Noorani, Rachael O’Brien, Smita Patel, Arthur Price, Tasneem Rahman, Suranjith Seneviratne, Anna Shrimpton, Catherine Stroud, Moira Thomas, Katie Townsend, Prashantha Vaitla, Nisha Verma, Anthony Williams, Siobhan O Burns, Sinisa Savic, Alex G Richter |
| 19 |
[GO] |
2022―Jan―27 |
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222 |
Deshni Jayathilaka, Chandima Jeewandara, Laksiri Gomes, Tibutius Thanesh Pramanayagam Jayadas, Achala Kamaladasa, Gayasha Somathilake, Dinuka Guruge, Pradeep Darshana Pushpakumara, Thushali Ranasinghe, Inoka Sepali Aberathna, Saubhagya Danasekara, Buddini Gunathilaka, Heshan Kuruppu, Ananda Wijewickrama, Ruwan Wijayamuni, Lisa Schimanski, T K Tan, Graham S Ogg, Alain Townsend, Gathsaurie Neelika Malavige |
| 20 |
[GO] |
2022―Jan―12 |
Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA |
Carly Rich, Daniel Eriksson, Fabrizio Dolfi, Katarzyna Jablonska, Firas Dabbous, Jameel Nazir |
| 21 |
[GO] |
2022―Jan―12 |
Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals? |
David Baker, Amy MacDougall, Angray S Kang, Klaus Schmierer, Gavin Giovannoni, Ruth Dobson |
| 22 |
[GO] |
2022―Jan―12 |
T cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients |
Arnold Awuah, Ava Zamani, Fariba Tahami, Mark Davis, Louis Grandjean, Matthew Buckland, Kimberly Gilmour |
| 23 |
[GO] |
2022―Jan―12 |
SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study |
Adrian M Shields, Srinivasan Venkatachalam, Salim Shafeek, Shankara Paneesha, Mark Ford, Tom Sheeran, Melanie Kelly, Iman Qureshi, Beena Salhan, Farheen Karim, Neelakshi De Silva, Jacqueline Stones, Sophie Lee, Jahanzeb Khawaja, Praveen Kumar Kaudlay, Richard Whitmill, Ghulam Nabi Kakepoto, Helen M Parry, Paul Moss, Sian E Faustini, Alex G Richter, Mark T Drayson, Supratik Basu |
| 24 |
[GO] |
2021―Jun―01 |
Human CD4
+
T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential |
Johan Verhagen, Edith D. van der Meijden, Vanessa Lang, Andreas E. Kremer, Simon Völkl, Andreas Mackensen, Michael Aigner, Anita N. Kremer |
| 25 |
[GO] |
2021―Feb―05 |
Innate and Adaptive Immune Responses to SARS-CoV-2 in Humans: Relevance to Acquired Immunity and Vaccine Responses |
Stanley C. Jordan |
| 26 |
[GO] |
2020―Nov―13 |
Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain. |
Sergi Cantenys-Molina, Eduardo Fernández-Cruz, Paloma Francos, Juan C Lopez Bernaldo de Quirós, Patricia Muñoz, Juana Gil-Herrera |
| 27 |
[GO] |
2020―Oct―30 |
A year in our understanding of COVID-19 |
R. S. Thwaites |
| 28 |
[GO] |
2020―Sep―26 |
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage |
Sandra Amor, Laura Fernández Blanco, David Baker |
| 29 |
[GO] |
2020―Sep―17 |
Vaccines for COVID-19 |
John S. Tregoning, Emily S. Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, Nana-Marie Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock |
| 30 |
[GO] |
2020―Aug―28 |
Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination |
Kurtuluş Aksu, Tuğba Naziroğlu, Pınar Özkan |
| 31 |
[GO] |
2020―Jul―24 |
Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19 |
Zhifeng Huang, Hao Chen, Mingshan Xue, Huimin Huang, Peiyan Zheng, Wenting Luo, Xueqing Liang, Baoqing Sun, Nanshan Zhong |
| 32 |
[GO] |
2020―Jul―16 |
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases |
David Baker, Charles AK Roberts, Gareth Pryce, Angray S Kang, Monica Marta, Saul Reyes, Klaus Schmierer, Gavin Giovannoni, Sandra Amor |
| 33 |
[GO] |
2020―May―04 |
Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19 |
Hongyan Hou, Bo Zhang, Hui Huang, Ying Luo, Shiji Wu, Guoxing Tang, Weiyong Liu, Lie Mao, Liyan Mao, Feng Wang, Ziyong Sun |
|
